Recruiting

Observational Study

Sponsor:

Cedars-Sinai Medical Center

Code:

NCT01304875

Conditions

Fabry Disease

Eligibility Criteria

Sex: Male

Age: 8 - 18

Healthy Volunteers: Not accepted

Study Details

Brief summary:

When to start children with Fabry disease on therapy is controversial because of its expense and inconvenience. Many Fabry children complain of exercise intolerance. In adults, the investigators have found decreased lung function and ability to exercise on a treadmill. Whether or not lung function and exercise capacity is abnormal in children is unknown. While lung function and exercise tests are commonly part of routine evaluations for adults with Fabry, they are not yet for children.

The objective of the proposed study is to more accurately define the lung and exercise abnormalities in a group of 20 boys from 8-18 years of age with Fabry disease who have not been treated with enzyme replacement therapy (Fabrazyme).

Conditions

Fabry Disease

Study ID

NCT01304875

Start date

Apr, 2010

Status verified date

Jun, 2013

Eligibility Criteria

Eligibility Criteria

Sex: Male

Age: 8 - 18

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Fabry disease
  • Male
  • Between 8-18 years of age
  • Enrolled in Fabry registry and have standard assessments

Exclusion Criteria:

  • Enzyme replacement therapy or an experimental therapy
  • Inability to perform the tests
  • Other, serious medical conditions that would impact the tests

Study Design

Enrollment

20 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Measurement of pulmonary function [ Time Frame: upon enrollment ]

Central Contacts and Locations

Central contacts

Locations

Cedars-Sinai Medical Center

Recruiting

Los Angeles, California, United States, 90048

Principal Investigator:

William R Wilcox, MD, PhD

More Information

Sponsor

Cedars-Sinai Medical Center

Last update posted

Jun 27, 2013

Last verified

Jun, 2013

Keywords

  • Fabry disease
  • alpha-galactosidase deficiency
  • exercise
  • pulmonary

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Cedars-Sinai Medical Center on 2013-06-27.